MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial
Daniel Rodriguez Gutierrez(Nottingham University Hospitals NHS Trust), Timothy Jaspan(Université Paris-Sud), Chris Jones(North Carolina State University), Robert A. Dineen(University of Nottingham), Esther Sánchez Aliaga(Radboud University Nijmegen), Monika Warmuth‐Metz, Marie‐Cécile Le Deley(Institut Gustave Roussy), Josep Garcia(Roche (Switzerland)), Gudrun Zahlmann(Quantitative BioSciences), Raphaël Calmon(Hôpital Necker-Enfants Malades), Amedeo A. Azizi(Medical University of Vienna), Darren Hargrave(Great Ormond Street Hospital), Jacques Grill(Institut Gustave Roussy), Gilles Vassal(Université Paris-Saclay), Alan Mackay(Institute of Cancer Research), Daniel Warren, Pascale Varlet(Inserm), Paul S. Morgan(Nottingham University Hospitals NHS Trust), Andrew C. Peet(Nottingham University Hospitals NHS Trust), Maura Massimino(Fondazione IRCCS Istituto Nazionale dei Tumori), Frank Saran(Institut Gustave Roussy), Adela Cañete(Universitat de València)
Cited by 26
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k